TNPSC Thervupettagam

Intranasal Covid vaccine

December 27 , 2022 693 days 620 0
  • Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose.
  • It will be introduced on the Co-WIN platform for those above 18 years of age.
  • The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories